Invaio Sciences secures $ 50 million debt financing



Invaio Sciences,Inc., a flagship company that harnesses the potential of natural systems to accelerate the transition to sustainable agriculture to urgently tackle climate change, has entered into a $ 50 million loan and security agreement with K2 HealthVentures ( K2HV), a healthcare and life sciences company. investment firm.

The funds will be used to accelerate the research, development and commercialization of Invaio platforms that focus on the discovery of natural active ingredients, the development of unique precision delivery systems and the understanding of new modes of delivery. ‘action. Invaio’s pioneering solutions have the potential to reduce the use of pesticides and chemical fertilizers, conserve more water, and improve the efficiency of the agricultural food system to benefit consumers and the planet.

“Invaio’s partnership with K2HV will help us expand our geographic presence and accelerate the development of revolutionary platforms focused on the development of integrated solutions in three market segments: perennials, row crops and market gardening”, said Ignacio Martinez, co-founder and CEO of Invaio and General Partner at Flagship Pioneering. “Our ambition is to create the most impactful and valuable crop health business on the planet. The world is changing rapidly and food production practices must adapt to keep up with changing consumer demands, changing environmental conditions and increased stress on ecological resources. “

“Fortunately, over the past two decades, the management of human disease has increasingly made use of safer and more effective precision medicine techniques. The agricultural world has not shifted to this paradigm and still suffers from inefficient management of pests and diseases and negative consequences for the environment. We believe Invaio’s platform technology suite is the precision medicine solution for the world of agriculture, ”said Parag Shah, founding CEO and CEO of K2 HealthVentures. “This funding follows our strategy of partnering with pioneering life science technology companies with world-class leadership that aim to provide solutions to critical global challenges. “

For more information:

Source link


About Author

Leave A Reply